Seegene highlights its advanced multiplex PCR technology and automated assay systems at ADLM 2024, offering solutions for rapid and accurate infectious disease diagnosis.
 |
| Seegene showcases its AIOS automated assay system at ADLM 2024, offering efficient and accurate PCR testing solutions for laboratories. |
Chicago, IL – August 2, 2024:
Seegene, a global leader in molecular diagnostics, made a significant presence at the Association for Diagnostics and Laboratory Medicine (ADLM) 2024 conference, held in Chicago from July 30 to August 1. Under the theme "One Sample, Many Answers," the company showcased its advanced multiplex PCR technology and automated assay systems.
Seegene unveiled its latest multiplexed real-time PCR products, designed to detect various infections, including respiratory, gastrointestinal, sexually transmitted, HPV, and antimicrobial resistance. The company also highlighted its Seegene STARlet-AIOS (AIOS) automated assay system, which streamlines the PCR testing process from sample to result.
"ADLM 2024 provided an excellent platform for Seegene to showcase our innovative multiplex PCR technology and automated solutions," said Daniel Shin, Executive Vice President and Head of Global Sales and Marketing at Seegene. "We are committed to advancing molecular diagnostics and improving global health."
Seegene's PCR technology is renowned for its ability to simultaneously test multiple pathogens in a single tube, providing accurate and timely results. The company's contributions during the COVID-19 pandemic, supplying over 340 million tests worldwide, underscore its expertise in this field.
ADLM brought together over 70,000 professionals from the laboratory medicine industry to share knowledge, collaborate, and explore the latest advancements in the field.
Seegene is a leading developer of multiplex PCR molecular diagnostics solutions. The company's technology enables simultaneous testing of multiple pathogens, providing accurate and rapid results.
The Association for Diagnostics and Laboratory Medicine (ADLM) is a global organization dedicated to advancing laboratory medicine and improving patient care.